Our observation that increased WNT signalling sensitizes colorectal cancers to centrosome loss even in the absence of p53 suggests that many, but not all, colorectal cancers might be treated therapeutically by targeting the centrosome. The gene discussed is TP53; the disease is colorectal cancer.